139062-90-1

Basic information

• Product Name: Carbamic acid, methyl-4-piperidinyl-, methyl ester (9CI)
• Synonyms: Carbamic acid, methyl-4-piperidinyl-, methyl ester (9CI);methyl methyl(piperidin-4-yl)carbamate
• CAS NO: 139062-90-1
• Molecular Formula: C₈H₁₆N₂O₂
• Molecular Weight: 172.22
• Mol File: 139062-90-1.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Carbamic acid, methyl-4-piperidinyl-, methyl ester (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, methyl-4-piperidinyl-, methyl ester (9CI)(139062-90-1)
• EPA Substance Registry System: Carbamic acid, methyl-4-piperidinyl-, methyl ester (9CI)(139062-90-1)

Safety Data

• Hazardous Substances Data: 139062-90-1(Hazardous Substances Data)

Upstream product

• 383865-57-4 4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl-amine 
• 220394-93-4 benzyl 4-(methoxycarbonylamino)piperidine-1-carboxylate 
• 220394-91-2 benzyl 4-isocyanatotetrahydro-1(2H)-pyridinecarboxylate 
• 220394-94-5 4-(methoxycarbonyl-methyl-amino)-piperidine-1-carboxylic acid benzyl ester 

Relevant articles and documents

Benzothiazole derivatives with activity as adenosine receptor ligands

The present invention relates to substituted benzothiazole derivitives and to their pharmaceutically acceptable salts useful for the treatment of diseases related to the adenosine receptor.

Aminopiperidine indanyl and benzocyclobutene compounds

The invention relates to new compounds of formula I: STR1 in which: m represents zero, 1, 2, 3 or 4, n and p represent zero, 1 or 2, W represents an oxygen atom, an --NH-- radical, or a single bond, R represents a benzocyclobuten-1-yl radical, or an indanyl radical, a 2,3-dihydrobenzofuran-2-yl R1 represents a hydrogen atom, an alkyl radical having from 1 to 6 carbon atoms, or an aryl radical, and R2 represents a hydrogen atom, an alkyl radical, an alkenyl radical, a cycloalkyl radical, a benzyl radical, a phenyl radical, an aralkyl radical, an alkoxyalkyl radical or a polyhalogenated alkyl radical, the optical isomers thereof and the addition salts thereof with a pharmaceutically acceptable organic or mineral acid, and medicaments containing the same.